
Number of publications published per year by Thorgeirsson, Snorri S.. (Source : PubMed)

Distribution of publications types for Thorgeirsson, Snorri S.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Stem cells in hepatocarcinogenesis: evidence from genomic data.
Semin. Liver Dis.
2010;30;1
Progenitor-derived hepatocellular carcinoma model in the rat.
Hepatology
2009

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.
Oncogene
2009;28;40

Identification of potential driver genes in human liver carcinoma by genomewide screening.
Cancer Res.
2009;69;9


Transcriptome analysis of liver cancer: ready for the clinic?
J. Hepatol.
2009;50;5

Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.
Cancer Res.
2009;69;7

E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.
Gastroenterology
2008;135;4


Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer.
Hepatology
2008;47;6
Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro.
Am. J. Pathol.
2008;172;5
Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
Clin. Cancer Res.
2008;14;7
[ See timeline ] [ See all publications ]
means that Thorgeirsson, Snorri S. has 54 papers cited a least 54 times - methodology
Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.